IMCR
Immunocore Holdings Ltd
NASDAQ: IMCR · HEALTHCARE · BIOTECHNOLOGY
$27.92
-3.02% today
Updated 2026-04-29
Market cap
$1.42B
P/E ratio
—
P/S ratio
3.55x
EPS (TTM)
$-0.71
Dividend yield
—
52W range
$27 – $41
Volume
0.4M
Immunocore Holdings Ltd (IMCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.30M | $10.29M | $16.93M | $20.21M | $19.17M | $23.65M | $25.67M | $30.11M | $27.04M | $144.23M | $197.39M | $247.98M | $297.57M |
| Revenue growth (YoY) | — | +211.7% | +64.6% | +19.4% | -5.2% | +23.4% | +8.5% | +17.3% | -10.2% | +433.3% | +36.9% | +25.6% | +20.0% |
| Cost of revenue | — | — | — | — | — | — | $99.99M | $74.81M | $74.13M | $5.29M | $820634.00 | $5.54M | $6.21M |
| Gross profit | $3.30M | $10.29M | $16.93M | $20.21M | $19.17M | $23.65M | $-74.32M | $-44.70M | $27.04M | $138.94M | $196.57M | $242.44M | $291.36M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -289.5% | -148.4% | 100.0% | 96.3% | 99.6% | 97.8% | 97.9% |
| R&D | $10.55M | $19.69M | $32.69M | $56.50M | $81.13M | $83.58M | $99.99M | $74.81M | $74.31M | $84.31M | $129.42M | $177.44M | $204.47M |
| SG&A | $1.88M | $3.99M | $4.41M | $4.60M | $29.22M | $34.16M | $44.18M | $45.74M | $119.31M | $93.72M | $154.85M | $155.78M | $165.41M |
| Operating income | $-7.74M | $-11.79M | $-20.18M | $-39.88M | $-90.78M | $-93.45M | $-118.32M | $-86.19M | $-129.42M | $-42.77M | $-47.20M | $-56.28M | $-33.74M |
| Operating margin | -234.3% | -114.6% | -119.2% | -197.3% | -473.7% | -395.1% | -460.9% | -286.2% | -478.5% | -29.7% | -23.9% | -22.7% | -11.3% |
| EBITDA | $-7.04M | $-10.64M | $-16.49M | $-36.57M | $-85.53M | $-86.75M | $-111.56M | $-82.38M | $-123.58M | $-38.35M | $-40.87M | $-38.50M | $387177.00 |
| EBITDA margin | -213.2% | -103.4% | -97.4% | -180.9% | -446.3% | -366.7% | -434.6% | -273.6% | -457.0% | -26.6% | -20.7% | -15.5% | 0.1% |
| EBIT | $-7.74M | $-11.79M | $-18.50M | $-39.88M | $-90.78M | $-93.45M | $-118.32M | $-88.83M | $-129.21M | $-42.77M | $-44.11M | $-41.86M | $-2.04M |
| Interest expense | — | — | — | $0.00 | $0.00 | $842000.00 | $3.80M | $3.11M | $5.57M | $5.41M | $4.08M | $18.84M | $12.17M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.96M | $-9.02M | $19.88M | $-28.40M | $-65.76M | $-71.63M | $-103.93M | $-74.09M | $-133.45M | $-43.46M | $-43.75M | $-40.81M | $-26.42M |
| Net income growth (YoY) | — | -51.3% | +320.3% | -242.9% | -131.5% | -8.9% | -45.1% | +28.7% | -80.1% | +67.4% | -0.7% | +6.7% | +35.3% |
| Profit margin | -180.6% | -87.7% | 117.4% | -140.5% | -343.1% | -302.8% | -404.9% | -246.0% | -493.4% | -30.1% | -22.2% | -16.5% | -8.9% |